XLO - Xilio Therapeutics, Inc.
IEX Last Trade
1.05
0 0%
Share volume: 100
Last Updated: Fri 10 Jan 2025 06:05:07 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.49%
PREVIOUS CLOSE
CHG
CHG%
$1.05
0.00
0.00%
Summary score
6%
Profitability
0%
Dept financing
36%
Liquidity
24%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-19.8%
Return on sales
-652.32%
Return on invested capital
0%
Total debt ratio
70.36%
Debt ratio change over timeo
0%
Current Ratio
1.93%
Quick Ratio
0%
Cash Position Ratio
1.34%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-19.8%
Return on sales
-652.32%
Return on invested capital
0%
Total debt ratio
70.36%
Debt ratio change over timeo
0%
Current Ratio
1.93%
Quick Ratio
0%
Cash Position Ratio
1.34%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-20.82%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
68.81%
Debt ratio change over time
0%
Current Ratio
2.19%
Quick Ratio
0%
Cash Position Ratio
1.08%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | XLO | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 13.03% | 18.15% | 6.63% |
| Return on assets | -19.8% | 2.28% | 3.22% | 5.84% |
| Return on sales | -652.32% | 27.95% | 31.46% | 43.41% |
| Return on invested capital | 0% | 2.07% | 5.53% | 34.89% |
| Profitability | 0% | 45% | 61% | 84% |
| Total debt ratio | 70.36% | 91.02% | 90.77% | 24.67% |
| Debt ratio change over time | 0% | 435.59% | 17.23% | -0.06% |
| Dept financing | 19% | 50% | 26% | 7% |
| Current Ratio | 1.93% | 0.82% | 1.41% | 3.64% |
| Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
| Cash Position Ratio | 1.34% | 0.31% | 0.49% | 2.77% |
| Liquididy | 22% | 12% | 27% | 75% |
| Short-term ratios | XLO | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 5.91% |
| Return on assets | -19.8% | 1.6% | 2.14% | 4.97% |
| Return on sales | -652.32% | 24.8% | 18.91% | 42.59% |
| Return on invested capital | 0% | 0% | 0% | 23.7% |
| Profitability | 0% | 23% | 22% | 100% |
| Total debt ratio | 70.36% | 94.49% | 93.35% | 24.56% |
| Debt ratio change over time | 0% | 0% | 0% | -0.62% |
| Dept financing | 44% | 25% | 25% | 6% |
| Current Ratio | 1.93% | 0.82% | 1.41% | 3.64% |
| Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
| Cash Position Ratio | 1.34% | 0.31% | 0.49% | 2.77% |
| Liquididy | 25% | 14% | 21% | 75% |